Rhythm Pharmaceuticals (RYTM) Inventory (2021 - 2026)

Rhythm Pharmaceuticals (RYTM) has reported Inventory for 6 consecutive years, with $28.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory rose 48.33% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $28.7 million (up 48.33% YoY), while the FY2025 annual figure was $25.8 million, up 37.42% from the prior year.
• Inventory rose to $28.7 million in Q1 2026 per RYTM's latest filing, from $25.8 million in the prior quarter.
• Across five years, Inventory topped out at $28.7 million in Q1 2026 and bottomed at $2.9 million in Q4 2022.
• Historically, Inventory has averaged $14.2 million across 5 years, with a median of $12.9 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory jumped 2527.93% — and 2025, when it surged 37.42%.
• Rhythm Pharmaceuticals' Inventory stood at $2.9 million in 2022, then jumped by 195.65% to $8.6 million in 2023, then soared by 117.31% to $18.7 million in 2024, then jumped by 37.42% to $25.8 million in 2025, then advanced by 11.25% to $28.7 million in 2026.
• Business Quant data shows RYTM's Inventory at $28.7 million in Q1 2026, $25.8 million in Q4 2025, and $22.1 million in Q3 2025.